Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Sepracor Phase III insomnia data

SEPR said Estorra eszopiclone improved latency to persistent sleep, sleep latency, sleep efficiency and total sleep time

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE